Please assess the completion status of the following clinical trial:

Trial Title: Interventions to Improve Specialty Medication Adherence

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The same medication (at the Generic Product Identifier level 12) filled ≥4 times in the 12 months before date of import into the study database~* Prescription generated from one of the following Vanderbilt outpatient specialty clinics: Pediatric Rheumatology, Pediatric Gastroenterology/Inflammatory Bowel Disease, adult Vanderbilt Rheumatology clinics, Dermatology, Hematology, Adult Endocrinology, Neurology, Asthma Sinus \& Allergy, Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension, Cystic Fibrosis, Multiple Sclerosis, Neurology, or a Lipid clinic~* Proportion of Days Covered (PDC) \< 90% over the previous 4 months and 12 months~Exclusion Criteria:~* Prescription issued by a non-VUMC provider~* Planned treatment discontinuation in the subsequent eight months~* More than one unique specialty medication from the same clinic in the previous four months~* Patients with \> 30 gap days in the previous four months and whose last fill was \> 30 days from importing into the study database.~* Any reason for misidentified nonadherence in the previous four months~* Deceased patients~* Incarcerated patients

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Pharmacist-Driven Intervention (Type: EXPERIMENTAL): The study group will receive a patient-tailored, pharmacist-driven intervention(s) to overcome patient-specific barriers to adherence. Each patient in the study group will be intervened upon using a protocol that is based on their reason for non-adherence.
- Standard of Care (Type: NO_INTERVENTION): The usual care group will receive the standard of care provided to all patients that utilize Vanderbilt Specialty Pharmacy.

Based on this trial design, predict the completion outcome and termination type (if applicable).